Seeking Alpha

chongkim74

chongkim74
Send Message
View as an RSS Feed
View chongkim74's Comments BY TICKER:
Latest  |  Highest rated
  • Vivus Up On Erectile Dysfunction Drug - What Should Investors Expect? [View article]
    You're reply to Chris's comment is a classic Forrest Gump response…but at least Gump had a heart of gold and was NOT racist.
    Sep 22, 2014. 11:38 PM | 1 Like Like |Link to Comment
  • Vivus Up On Erectile Dysfunction Drug - What Should Investors Expect? [View article]
    Cheers ma arsh..Yes, Im an oriental, and not Asian…and yes for that you may call all of us "Wang"…hey cuz we look alike right?! I wish I had you proximity of driving distance...
    Sep 22, 2014. 11:35 PM | Likes Like |Link to Comment
  • Vivus Up On Erectile Dysfunction Drug - What Should Investors Expect? [View article]
    Jake101 Prime example…but still what, Jake? You should be so lucky.
    Sep 22, 2014. 11:33 PM | Likes Like |Link to Comment
  • Vivus Up On Erectile Dysfunction Drug - What Should Investors Expect? [View article]
    When they say "ignorance is bliss," your face, Jake101, is all over it~
    Sep 22, 2014. 11:32 PM | Likes Like |Link to Comment
  • Vivus Up On Erectile Dysfunction Drug - What Should Investors Expect? [View article]
    Dude…you aint #&^@! to me. I aint your son and quite frankly, I maybe supposedly younger than you are, but exceedingly and diversely educated than you…Racist idiot..Call me "Wang" again…as it is evident my name is Chong Kim.
    Sep 22, 2014. 11:29 PM | Likes Like |Link to Comment
  • Vivus Up On Erectile Dysfunction Drug - What Should Investors Expect? [View article]
    Dude..stop leading astray of people interested in VVUS. Short term projection is a fairly valued 4.75 to 5.00$. Racist "ma papa used to tell me" idiot.
    Sep 22, 2014. 11:26 PM | Likes Like |Link to Comment
  • Vivus Up On Erectile Dysfunction Drug - What Should Investors Expect? [View article]
    @Jake101. You are 101. Basic and really acute...You're an ignorant trying to be educated and creating followers to your BS stock purchase price of VVUS. Im sorry to tell you, SON! I bought VVUS at a good price...We are very realistic, in short term, to get close to $5.00…And allow me to retort to your past comment about asking you for advice…I would get better advice from a blind man for directions, rather than a PIG like you. "My papa used to tell me…" lol give me a break..by the way your racial comments are, you probably don't have a papa or mama, cuz if you did, they would educate you with multicultural etiquette. I still don't believe you called me "Wang"…lol What a ignorant racist person you are. Im done with u, fool. Go on and tell us "what your pappee used to say." lol
    Sep 22, 2014. 11:23 PM | 1 Like Like |Link to Comment
  • Vivus Up On Erectile Dysfunction Drug - What Should Investors Expect? [View article]
    Heres some open info:

    Auxilium agreement expiration is 2018, however a year and half Vivus may terminate. So far $45 mil. plus label expansion payout.
    They will pay off Mitsubishi IOUs. Guaranteed payout supply chain deal starts from 2015. Regulatory and sales milestones payout up to $255 mill. and it started with label expansion. 150 dedicated employees…Vivus is waiting for a milestone response and a new marketing and distribution strategy from them as we speak. Wait about couple of months and you will see a flux of social media and digital marketing, and B2B promotional factors…Its amazing for me to say but that 15 minute on demand response followed by less side effects coupled by lower pricing is a game changer for me. I don't expect this stock to go insane, but I see upper 4s to 5s expeditiously.
    Sep 22, 2014. 05:36 PM | Likes Like |Link to Comment
  • Vivus Up On Erectile Dysfunction Drug - What Should Investors Expect? [View article]
    Auxilium merger WILL help the distribution, marketing and sales of Stendra. Waiting for the result.
    Sep 22, 2014. 05:06 PM | Likes Like |Link to Comment
  • Investing In Dunkin' Brands: Weighing The Pros Against The Cons [View article]
    Granted…I believe it will prepare for the next QE. No more excuses. Their expansion is on route. Fall is one of better seasons. This bounce was called due to the analyst ratings before. Soon I expect bottom, then coming up with solid graph. My two cents. Well see…I feel BAC is going for a short fall as well.
    Sep 22, 2014. 04:55 PM | Likes Like |Link to Comment
  • Vivus Up On Erectile Dysfunction Drug - What Should Investors Expect? [View article]
    @Jake101 It pisses me off that a redneck, ignorant, racist hillbillies like you still voting for elections in America. I do not appreciate you stereotyping my name by adding a "wang" in it. You must be some stubborn hay grazing cow to even attempt a racial remark here in SA. You're name sounds smart as a mail order workout machine you hang on doors…

    Having said that, Qsymia is going to cost the company at least $200 mill. until 2015 for their mishap with the FDA. This is a learning experience that cost investors a lot of money. Im sorry you had this stock for a long time. I was aware about this stock but was not happy with another product in the market that is so controversial and health hazard. There may be some make-up gain in the future, but it is not doing too well currently.

    Im on board thanks to Stendra. I will not entertain your racist wrinkly arsh to tell you why Im on board. All Im going to say is Auxilium will HAVE to gear up
    their marketing and manpower with the label extension.

    "You think education is expensive, try ignorance."
    Sep 22, 2014. 04:44 PM | Likes Like |Link to Comment
  • Vivus Up On Erectile Dysfunction Drug - What Should Investors Expect? [View article]
    @Jake101
    Foremost, it pisses me off that a redneck, ignorant, racist hillbillies like you still voting for elections in America. I do not appreciate you stereotyping my name by adding a "wang" in it. You must be some stubborn hay grazing cow to even attempt a racial remark here in SA. You're name sounds smart as a mail order workout machine you hang on doors…

    Having said that, Qsymia is going to cost the company at least $200 mill. until 2015 for their mishap with the FDA. This is a learning experience that cost investors a lot of money. Im sorry you had this stock for a long time. I was aware about this stock but was not happy with another product in the market that is so controversial and health hazard. There may be some make-up gain in the future, but it is not doing too well currently.

    Im on board thanks to Stendra. I will not entertain your racist wrinkly arsh to tell you why Im on board. All Im going to say is Auxilium will HAVE to gear up
    their marketing and manpower with the label extension.

    "You think education is expensive, try ignorance."
    Sep 22, 2014. 04:43 PM | 1 Like Like |Link to Comment
  • Analysis: Headwinds for Dunkin' Brands in California [View news story]
    Good entry pt. coming up shortly...
    Sep 22, 2014. 04:15 PM | Likes Like |Link to Comment
  • Investing In Dunkin' Brands: Weighing The Pros Against The Cons [View article]
    Good buying opportunity coming up with DNKN.
    Sep 22, 2014. 04:09 PM | Likes Like |Link to Comment
  • Fidelity Owns The UC Sector: Could AudioCodes Be Next? [View article]
    Thanks..
    Sep 19, 2014. 05:48 PM | Likes Like |Link to Comment
COMMENTS STATS
755 Comments
365 Likes